Brokerages Set Novozymes A/S (OTCMKTS:NVZMY) Price Target at $425.00

Novozymes A/S (OTCMKTS:NVZMYGet Rating) has received a consensus rating of “Hold” from the nine ratings firms that are presently covering the stock, Marketbeat Ratings reports. Two investment analysts have rated the stock with a sell recommendation, four have assigned a hold recommendation and two have issued a buy recommendation on the company. The average 1-year price objective among brokers that have covered the stock in the last year is $425.00.

Several brokerages have weighed in on NVZMY. Credit Suisse Group cut their price target on Novozymes A/S from 390.00 to 360.00 and set an “underperform” rating on the stock in a report on Friday, February 4th. Deutsche Bank Aktiengesellschaft raised Novozymes A/S from a “hold” rating to a “buy” rating in a research report on Wednesday, March 30th. Nordea Equity Research raised Novozymes A/S from a “sell” rating to a “hold” rating in a research report on Wednesday, April 27th. Zacks Investment Research raised Novozymes A/S from a “sell” rating to a “hold” rating in a research report on Thursday. Finally, Kepler Capital Markets raised Novozymes A/S from a “reduce” rating to a “hold” rating in a research report on Friday, April 29th.

Shares of OTCMKTS NVZMY opened at $64.71 on Friday. The stock’s 50-day moving average is $66.07 and its two-hundred day moving average is $70.56. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.38 and a quick ratio of 0.85. Novozymes A/S has a 1-year low of $57.85 and a 1-year high of $83.31. The company has a market cap of $14.77 billion, a price-to-earnings ratio of 37.19, a price-to-earnings-growth ratio of 9.27 and a beta of 0.57.

The business also recently disclosed a dividend, which was paid on Tuesday, April 5th. Shareholders of record on Friday, March 18th were given a dividend of $0.567 per share. The ex-dividend date was Thursday, March 17th. This represents a yield of 0.95%. Novozymes A/S’s payout ratio is 31.61%.

About Novozymes A/S (Get Rating)

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Europe, the Middle East, Africa, North America, the Asia Pacific, and Latin America. The company offers baking, beverages, dairy, starch, and protein solutions for the food and beverage industry; laundry, dishwashing, and professional cleaning solutions for the household care industry; agriculture solutions, including crop production, and animal health and nutrition solutions; bioyield and biocontrol solutions for crops; and grain and technical processing solutions, as well as bio energy solutions for liquefaction, saccharifaction, fermentation, fiber conversion, and biomass conversion.

See Also

Analyst Recommendations for Novozymes A/S (OTCMKTS:NVZMY)

Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with MarketBeat.com's FREE daily email newsletter.